<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id><journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id><journal-id journal-id-type="publisher-id">ci</journal-id><journal-id journal-id-type="coden">jcisd8</journal-id><journal-title-group><journal-title>Journal of Chemical Information and Modeling</journal-title></journal-title-group><issn pub-type="ppub">1549-9596</issn><issn pub-type="epub">1549-960X</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39916334</article-id><article-id pub-id-type="pmc">PMC11863380</article-id>
<article-id pub-id-type="doi">10.1021/acs.jcim.4c02252</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>CaBind_MCNN: Identifying Potential Calcium Channel
Blocker Targets by Predicting Calcium-Binding Sites in Ion Channels
and Ion Transporters Using Protein Language Models and Multiscale
Feature Extraction</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-8411-6363</contrib-id><name><surname>Chang</surname><given-names>Yan-Yun</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-1670-649X</contrib-id><name><surname>Liu</surname><given-names>Yu-Chen</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0009-7380-5954</contrib-id><name><surname>Jhang</surname><given-names>Wei-En</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Wei</surname><given-names>Sin-Siang</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9894-926X</contrib-id><name><surname>Ou</surname><given-names>Yu-Yen</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Computer Science and Engineering, <institution>Yuan
Ze University</institution>, Chung-Li 32003, <country>Taiwan</country></aff><aff id="aff2"><label>&#x02021;</label>Graduate
Program in Biomedical Informatics, <institution>Yuan
Ze University</institution>, Chung-Li 32003, <country>Taiwan</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>yien@saturn.yzu.edu.tw</email>.</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>02</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>24</day><month>02</month><year>2025</year></pub-date><volume>65</volume><issue>4</issue><fpage>2145</fpage><lpage>2157</lpage><history><date date-type="received"><day>03</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>09</day><month>01</month><year>2025</year></date><date date-type="rev-recd"><day>03</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0008" id="ab-tgr1"/></p><p>Calcium ions (Ca<sup>2+</sup>) are crucial for various physiological
processes, including neurotransmission and cardiac function. Dysregulation
of Ca<sup>2+</sup> homeostasis can lead to serious health conditions
such as cardiac arrhythmias and hypertension. Ion channels and transporters
play a vital role in maintaining cellular Ca<sup>2+</sup> balance
by facilitating Ca<sup>2+</sup> transport across cell membranes. Accurate
prediction of Ca<sup>2+</sup> binding sites within these proteins
is essential for understanding their function and identifying potential
therapeutic targets, particularly for developing novel calcium channel
blockers (CCBs). This study introduces CaBind_MCNN, an innovative
computational model that leverages pretrained protein language models
(PLMs) and a multiscale feature extraction approach to predict Ca<sup>2+</sup> binding sites in ion channels and transporter proteins.
Our method integrates embeddings from the ProtTrans PLM with a convolutional
neural network (CNN)-based multiwindow scanning approach, capable
of capturing diverse sequence features relevant to Ca<sup>2+</sup> binding. The model, trained on a curated data set of 27 calcium-binding
protein sequences, achieves high accuracy with an area under the curve
(AUC) of 0.9886, significantly outperforming some existing methods.
These results demonstrate the potential of CaBind_MCNN to enhance
drug discovery efforts by identifying potential CCB targets and advancing
the development of novel therapies for calcium-related disorders.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>National Science and Technology Council</institution><institution-id institution-id-type="doi">10.13039/501100020950</institution-id></institution-wrap></funding-source><award-id>NSTC 112-2221-E-155-020-MY3</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ci4c02252</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ci4c02252</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Calcium
(Ca<sup>2+</sup>) is the most abundant mineral in the human
body, with 99% stored in bones and teeth, while the remaining 1% is
distributed in blood, muscle, nerve cells, and other tissues. Calcium
plays a crucial role in maintaining overall health by regulating various
physiological processes through its interaction with different proteins.
These processes include neurotransmission,<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> muscle
contraction, and relaxation, particularly in the heart. Calcium&#x02019;s
role in cardiac functions<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> is mediated through ion channels
and transporter proteins, which are integral components of the cell
membrane responsible for the transmembrane movement of calcium ions.</p><p>Ion channels<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> and ion transporter proteins<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> are essential for cellular function, controlling
the movement of molecules and ions across cellular membranes. Their
fundamental roles in cellular physiology make them key drug targets.
Dysfunction of these proteins is directly associated with a wide range
of diseases, including cardiovascular, neurological, and metabolic
disorders, as well as cancer. Computational advancements<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> have significantly improved our ability to accurately identify these
crucial membrane proteins. Ion transporter proteins, such as the sodium&#x02013;calcium
exchanger (NCX)<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> in cardiac myocytes, maintain
essential intracellular environments by regulating calcium efflux.
Similarly, ion channels, like calcium channels (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), provide selective pathways for ion flow,
with intricate binding sites controlling permeation and electrochemical
gradients vital for signaling.<sup><xref ref-type="bibr" rid="ref13">13</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref></sup> The strong link between malfunctioning
ion channels and transporters and various diseases makes them attractive
targets for therapeutic development.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Red areas show where the channel binds
to calcium.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0001" id="gr1" position="float"/></fig><p>Arrhythmia<sup><xref ref-type="bibr" rid="ref16">16</xref>&#x02212;<xref ref-type="bibr" rid="ref18">18</xref></sup> is one of the
most common heart conditions, characterized
by irregular heart rhythms due to abnormal cardiac signal conduction.
The mechanisms behind this condition are extremely complex and difficult
to predict. It is closely related to other cardiovascular diseases,
potentially leading to heart failure and sudden death. Excessive accumulation
of calcium ions is considered a key factor in inducing apoptosis in
cardiomyocytes apoptosis,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> resulting in arrhythmias.
Clinically, to address these heart issues caused by calcium ion imbalances,
a class of drugs known as calcium channel blockers (CCBs) has been
developed.</p><p>In <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>, CCBs<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> work by binding to calcium channel
proteins and altering their structure
to prevent calcium ions from entering the cell, decreasing intracellular
calcium concentrations. This results in the relaxation of vascular
smooth muscle, reduction of blood pressure, and alleviation of symptoms
such as palpitations and arrhythmias. However, there are still some
limitations to the clinical application of current CCBs.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> Some patients may have poor tolerance to these drugs, potentially
experiencing side effects such as hypotension, dizziness, and fatigue
that limit the long-term use of CCBs. Additionally, some CCBs may
reduce the heart&#x02019;s contractility, leading to incomplete cardiac
output, which is particularly detrimental for patients with heart
failure. Furthermore, when CCBs are used in combination with other
medications, they may excessively lower the heart rate or result in
an atrioventricular conduction block.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Two types of CCBs and their mechanisms
of action</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0002" id="gr2" position="float"/></fig><p>While existing CCBs have played
a crucial role in treating (such
as arrhythmias, hypertension as shown in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>, and angina) or preventing (such as stone
heart) various heart-related diseases, their limitations are numerous,
and they may not be safe for all patients. In this context, our CaBind_MCNN
model can provide significant assistance in discovering new CCBs by
predicting their calcium binding sites. This model can accurately
predict the binding positions of calcium ions on different channel
proteins and transporter proteins, which not only helps identify novel
potential drug targets but may also reveal further details about existing
drugs&#x02019; mechanisms. For example, by analyzing these binding
sites, researchers can design drugs specifically targeting certain
calcium channel varieties, or adjust the structure of existing CCBs
to improve their specificity and effectiveness, thus reducing side
effects.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Effect of CCBs on hypertension.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0003" id="gr3" position="float"/></fig><p>Several other research groups have also proposed methods for predicting
Ca<sup>2+</sup> ion binding positions. For instance, Ying Xia&#x02019;s
team developed GraphBind,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> which utilizes
graph neural networks (GNNs) to construct graphs based on a protein&#x02019;s
structural context. Their approach involves building graphs of the
highly neighboring residues around a target residue, followed by applying
hierarchical graph neural networks (HGNNs) to embed structural and
latent features for binding residue recognition. Another example is
Jian Zhang&#x02019;s team&#x02019;s method, SCAMPER,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> which leverages the BioLip database, enhancing data quality
through re-editing. SCAMPER&#x02019;s architecture consists of two
layers: an initial layer for basic predictions and a second layer
to rank the results from the first layer, employing 5-fold cross-validation
to minimize prediction errors. While these models offer valuable approaches,
they can be computationally intensive and time-consuming. To address
this, we propose CaBind_MCNN, a model designed for high prediction
accuracy and efficient computation, by combining current popular pretrained
language models with multiwindow scanning.</p><p>CaBind_MCNN, a novel
model that leverages the power of pretrained
protein language models (PLMs) and multiwindow scanning to achieve
high prediction accuracy with reduced computational complexity. This
approach can facilitate the identification of potential CCB targets
by pinpointing Ca<sup>2+</sup> binding sites in ion channels and transporter
proteins, paving the way for developing of novel therapies. In this
study, we demonstrate the effectiveness of CaBind_MCNN in accurately
predicting Ca<sup>2+</sup> binding sites within VGCCs and NCXs. We
show that our model outperforms existing methods, particularly in
sensitivity, highlighting its potential for discovering novel CCB
binding sites and advancing drug development for calcium-related disorders.
Our findings provide valuable insights into the molecular mechanisms
of Ca<sup>2+</sup> regulation and offer a powerful tool for accelerating
the discovery of new therapeutic targets.</p></sec><sec id="sec2"><title>Materials and Methods</title><p>In <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, this
figure presents the workflow for predicting calcium binding sites
in ion channels and transporter proteins. The process begins with
data collection from the UniProt database, followed by preprocessing
to ensure a diverse data set for training and validation. Protein
sequences are then transformed into high-dimensional embeddings using
a pretrained protein language model (such as ProtTrans), capturing
key biological signals. The multiple window scanning neural network
(MCNN) scans these embeddings at various scales, identifying potential
calcium-binding residues. The extracted features are classified to
distinguish between calcium-interacting and noninteracting residues,
with predictions validated against independent data sets to ensure
robustness and accuracy. This workflow showcases the effective integration
of protein language models and deep learning to improve protein function
prediction.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Workflow for Ca<sup>2+</sup> binding site prediction model.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0004" id="gr4" position="float"/></fig></sec><sec id="sec3"><title>Data Collection</title><p>Our study focused
on identifying calcium-binding sites in proteins,
with a particular emphasis on ion channels and transporters relevant
to calcium channel blocker (CCB) activity. Data was sourced from multiple
databases and curated to ensure high quality and minimize redundancy.</p><sec id="sec3.1"><title>Initial
Data Set: Ion Channels and Transporters</title><p>Initially,
we focused on ion channel and transporter proteins known to bind calcium
ions, sourcing our data from the UniProt database. We identified 155
relevant protein sequences. To maintain diversity and reduce redundancy,
we used the CD-HIT tool for similarity comparison, retaining only
those sequences with less than 30% sequence identity. This process
yielded an initial data set of 27 sequences, containing 142 calcium-binding
residues and 26,600 nonbinding residues. This data set was partitioned
into training and validation subsets using an 80:20 ratio. The training
set comprised 21 sequences (111 calcium-binding residues, 22,873 nonbinding
residues), and the validation set contained 6 sequences (31 calcium-binding
residues, 3,727 nonbinding residues).</p></sec><sec id="sec3.2"><title>Independent Test Set: Calcium
Channel Blocker Targets from ChEMBL</title><p>To further enhance the
robustness and pharmacological relevance
of our study, and following suggestions to validate our methods against
well-characterized drug targets, we constructed an additional independent
test set derived from the ChEMBL database. We searched ChEMBL for
proteins annotated as targets for Calcium Channel Blockers (CCBs).
This search yielded 50 UniProt entries. To ensure data set diversity
and reduce redundancy, we applied a 40% CD-HIT similarity threshold,
resulting in a final data set of 23 calcium channel protein sequences.
This data set provides a valuable resource for evaluating our model&#x02019;s
ability to predict calcium-binding sites in proteins directly relevant
to CCB activity and allows for a more comprehensive comparison with
existing prediction methods. The detailed breakdown of this data set
is provided in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Statistics of the Survey Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">data set</th><th style="border:none;" align="center">protein sequence with Ca<sup>2+</sup> binding
residue</th><th style="border:none;" align="center">similarity &#x0003c; 30%</th><th style="border:none;" align="center">training</th><th style="border:none;" align="center">testing</th></tr></thead><tbody><tr><td style="border:none;" align="left">ion channel/ion transport</td><td style="border:none;" align="center">155</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">21</td><td style="border:none;" align="center">6</td></tr></tbody></table><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">data set</th><th style="border:none;" align="center">protein sequences</th><th style="border:none;" align="center">Ca<sup>2+</sup> binding residues</th><th style="border:none;" align="center">nonbinding
residues</th></tr></thead><tbody><tr><td style="border:none;" align="left">training data</td><td style="border:none;" align="center">21</td><td style="border:none;" align="center">111</td><td style="border:none;" align="center">22873</td></tr><tr><td style="border:none;" align="left">testing data</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">31</td><td style="border:none;" align="center">3727</td></tr></tbody></table><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">data set</th><th style="border:none;" align="center">protein sequence with Ca<sup>2+</sup> binding
residue</th><th style="border:none;" align="center">similarity &#x0003c; 40</th><th style="border:none;" align="center">Ca<sup>2+</sup> binding residues</th><th style="border:none;" align="center">nonbinding residues</th></tr></thead><tbody><tr><td style="border:none;" align="left">calcium channel from ChEMBL</td><td style="border:none;" align="center">50</td><td style="border:none;" align="center">23</td><td style="border:none;" align="center">177</td><td style="border:none;" align="center">23640</td></tr></tbody></table></table-wrap><p><xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> summarizes
the composition of all data sets used in this study. While the initial
data set of ion channels and transporters is relatively small (27
sequences after redundancy removal), this is due to the stringent
requirement for experimentally validated calcium-binding sites within
these specific protein classes. The addition of the ChEMBL-derived
data set significantly expands our evaluation by focusing on proteins
directly involved in CCB interactions, thus enhancing the translational
relevance of our findings and addressing concerns about the initial
data set&#x02019;s size. All data sets underwent rigorous curation
to ensure high quality and minimize redundancy.</p></sec><sec id="sec3.3"><title>Embedding Generation
with Pretrained Protein Language Models</title><p>To capture the complex
sequence patterns and structural information
crucial for predicting calcium-binding sites, we used protein PLMs
from the ProtTrans<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> series. PLMs are powerful
tools based on the pretraining concept from natural language processing,
applied to protein sequence analysis. These models undergo unsupervised
pretraining on large-scale protein sequence data sets, acquiring structural
and functional information within protein sequences. This allows them
to generate high-dimensional embeddings that capture the subtle differences
and contextual dependencies of the sequences.</p><p>ProtT5-XL-UniRef50,
an advanced protein language model based on the Transformer architecture,
was pretrained on a deredundant protein sequence collection, ProtT5-XL-UniRef50,
enabling the ProtTrans model to learn the common features prevalent
across diverse protein families. The high-dimensional embedding vectors
generated by the ProtT5-XL-UniRef50 model (up to 1024 dimensions)
encapsulate rich sequence features, which include not only basic amino
acid sequence information but also deeper structural and functional
insights. This enables ProtTrans to make more detailed and accurate
predictions than traditional methods based on manual feature identification,
particularly when dealing with complex biological problems. By identifying
contextual information within sequences, ProtTrans can identify potential
functional domains and interaction sites, which is essential for predicting
key biological functions like calcium-binding sites.</p></sec><sec id="sec3.4"><title>Multiscale
Feature Extraction with Multiple Window Scanning</title><p>We implemented
a multiple window scanning technique,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> an extension of convolutional neural networks
(CNNs), to extract features at varying scales across the protein sequences.
This method involves scanning the sequence embeddings with windows
of different sizes to capture both local and global sequence features.
For each window size, the CNN computes the weighted sum over overlapping
regions, generating a vector representation for each window. We applied
max-pooling to each vector to retain the most significant features,
which were then concatenated and passed through a fully connected
layer to produce the final predictions.</p><p>The choice of window
sizes was carefully optimized based on performance metrics, with window
lengths ranging from 2 to 12. Our experiments revealed that a combination
of windows sizes 6, 8, 10, and 12 yielded the highest predictive accuracy,
balancing the capture of local and global features.</p></sec></sec><sec id="sec4"><title>Performance Evaluation</title><p>The predictive model was trained using the training data set, with
hyperparameters tuned to maximize performance on the validation set.
The model&#x02019;s effectiveness was evaluated using standard metrics,
including sensitivity, specificity, accuracy, matthews correlation
coefficient (MCC), and area under the receiver operating characteristic
curve (AUC). Sensitivity and specificity were particularly critical
for assessing the model&#x02019;s ability to correctly identify calcium-binding
and nonbinding residues, respectively.</p><p>To validate the robustness
of our model, we conducted additional
experiments comparing its performance with different filter sizes,
window lengths, and feature sets, including protein PLMs, ESM-2, and
TAPE embeddings. The results consistently demonstrated the superiority
of our protein PLMs-based model, particularly in independent test
scenarios, where it achieved an AUC of 0.9886, significantly outperforming
other models.<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_m001" position="anchor"/><label>1</label></disp-formula><disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_m002" position="anchor"/><label>2</label></disp-formula><disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_m003" position="anchor"/><label>3</label></disp-formula><disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_m004" position="anchor"/><label>4</label></disp-formula></p><p>These metrics are based on the classification of predictions
into
four categories: True Positives (TP), True Negatives (TN), False Positives
(FP), and False Negatives (FN). Sensitivity, also known as recall,
measures the proportion of actual positive cases (Ca<sup>2+</sup> binding
residues) correctly identified by the model. Specificity quantifies
the proportion of actual negative cases (nonbinding residues) correctly
classified. Accuracy reflects the overall proportion of correct predictions,
regardless of the class. MCC provides a balanced measure of the model&#x02019;s
performance, considering all four classification categories, and ranges
from &#x02212;1 (total disagreement between prediction and observation)
to +1 (perfect prediction), with 0 indicating random performance.
AUC, calculated as the area under the ROC curve, represents the model&#x02019;s
ability to distinguish between positive and negative cases across
different classification thresholds. An AUC value of 1 signifies perfect
discrimination, while a value of 0.5 indicates random classification.
Our model&#x02019;s performance in predicting calcium binding sites
within ion channels and transporter proteins was rigorously evaluated
using the above four metrics. Among these, AUC was our primary evaluation
criterion, given its robustness in summarizing the model&#x02019;s
performance across different threshold settings.</p><sec id="sec4.1"><title>The Performance Comparison
with Different Single Window Sizes</title><p>We first analyzed the
impact of different single window sizes on
model performance. As shown in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, we observed a gradual increase in AUC values as the
window size increased, with a peak of 0.9796 at a window size of 12.
This trend suggests that larger windows more effectively capture sequence
features relevant to calcium-binding sites, as they encompass a broader
sequence context, thereby providing a more comprehensive reflection
of calcium-binding site background information. However, once the
window size reaches a certain size, performance gains diminish. This
may be due to the introduction of irrelevant sequence information,
which negatively impacts prediction accuracy. Therefore, adjusting
the window size must consider the effectiveness and relevance of the
sequence information to ensure that the model captures valid information
while minimizing the influence of irrelevant data. Optimizing window
size therefore becomes a critical step in improving model accuracy.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Performance Comparison with Different
Single Window Sizes</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">single window
sizes</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup></th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="center">0.9034</td><td style="border:none;" align="center">0.9028</td><td style="border:none;" align="center">0.9028</td><td style="border:none;" align="center">0.1992</td><td style="border:none;" align="center">0.9479</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="center">0.9148</td><td style="border:none;" align="center">0.9062</td><td style="border:none;" align="center">0.9062</td><td style="border:none;" align="center">0.2046</td><td style="border:none;" align="center">0.9481</td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="center">0.9241</td><td style="border:none;" align="center">0.9136</td><td style="border:none;" align="center">0.9137</td><td style="border:none;" align="center">0.2110</td><td style="border:none;" align="center">0.9607</td></tr><tr><td style="border:none;" align="left">8</td><td style="border:none;" align="center">0.9282</td><td style="border:none;" align="center">0.9261</td><td style="border:none;" align="center">0.9261</td><td style="border:none;" align="center">0.2281</td><td style="border:none;" align="center">0.9661</td></tr><tr><td style="border:none;" align="left">10</td><td style="border:none;" align="center">0.9436</td><td style="border:none;" align="center">0.9379</td><td style="border:none;" align="center">0.9379</td><td style="border:none;" align="center">0.2642</td><td style="border:none;" align="center">0.9748</td></tr><tr><td style="border:none;" align="left">12</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9284</td><td style="border:none;" align="center">0.9286</td><td style="border:none;" align="center">0.2527</td><td style="border:none;" align="center">0.9796</td></tr></tbody></table></table-wrap></sec><sec id="sec4.2"><title>The Performance Comparison with Different
Window Combinations</title><p>Next, we further evaluated model performance
using combinations
of different window sizes. The window selection order was based on
the AUC ranking from high to low in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. As shown in <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>, the combination of window sizes 6, 8, 10,
and 12 achieved the highest AUC value of 0.9860. This result underscores
the advantages of a multiscale approach, where different window sizes
identify complementary aspects of sequence features, leading to more
comprehensive and accurate predictions. The success of multiwindow
combinations illustrates the complexity of calcium-binding sites,
which may involve interactions across multiple sequence scales. While
a single window can only capture sequence information at a specific
scale, multiple windows can integrate information from different sizes.
This allows the model to capture local motifs and recognize broader
sequence patterns, greatly enhancing its predictive capabilities.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Performance Comparison with Different
Window Combinations<xref rid="t3fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">window combinations</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">[12]</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9284</td><td style="border:none;" align="center">0.9286</td><td style="border:none;" align="center">0.2527</td><td style="border:none;" align="center">0.9796</td></tr><tr><td style="border:none;" align="left">[12, 10]</td><td style="border:none;" align="center">0.9618</td><td style="border:none;" align="center">0.9443</td><td style="border:none;" align="center">0.9444</td><td style="border:none;" align="center">0.2994</td><td style="border:none;" align="center">0.9810</td></tr><tr><td style="border:none;" align="left">[12, 10, 8]</td><td style="border:none;" align="center">0.9743</td><td style="border:none;" align="center">0.9497</td><td style="border:none;" align="center">0.9498</td><td style="border:none;" align="center">0.3099</td><td style="border:none;" align="center">0.9849</td></tr><tr><td style="border:none;" align="left"><bold>[12, 10,
8, 6]</bold></td><td style="border:none;" align="center"><bold>0.9828</bold></td><td style="border:none;" align="center"><bold>0.9546</bold></td><td style="border:none;" align="center"><bold>0.9548</bold></td><td style="border:none;" align="center"><bold>0.3206</bold></td><td style="border:none;" align="center"><bold>0.9860</bold></td></tr><tr><td style="border:none;" align="left">[12,10, 8, 6, 4]</td><td style="border:none;" align="center">0.9597</td><td style="border:none;" align="center">0.9505</td><td style="border:none;" align="center">0.9506</td><td style="border:none;" align="center">0.2857</td><td style="border:none;" align="center">0.9824</td></tr><tr><td style="border:none;" align="left">[12,10, 8, 6, 4, 2]</td><td style="border:none;" align="center">0.9618</td><td style="border:none;" align="center">0.9541</td><td style="border:none;" align="center">0.9541</td><td style="border:none;" align="center">0.3085</td><td style="border:none;" align="center">0.9820</td></tr></tbody></table><table-wrap-foot><fn id="t3fn1"><label>a</label><p>The bolded row indicates the configuration
selected for the final model.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec4.3"><title>Optimizing the Number of Convolutional Filters</title><p>We investigated
the impact of the number of convolutional filters on model performance.
As shown in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>, we evaluated filter sizes ranging from 64 to 2048, using the optimal
multiwindow configuration determined previously. A filter size of
64 achieved the highest AUC (0.9886), along with excellent sensitivity
(0.9799) and specificity (0.9636). Increasing the number of filters
beyond 64 did not yield further improvements and, in some cases, slightly
reduced performance. This observation highlights the critical balance
between model complexity and generalization ability in deep learning.
While more filters can capture richer features, an excessively complex
model risks overfitting to the training data, hindering its ability
to generalize to unseen examples. Therefore, 64 filters provided the
optimal balance, allowing the model to learn relevant patterns without
overfitting.</p><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><title>Performance Comparison with Different
Filter Sizes<xref rid="t4fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">filters sizes</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>64</bold></td><td style="border:none;" align="center"><bold>0.9799</bold></td><td style="border:none;" align="center"><bold>0.9636</bold></td><td style="border:none;" align="center"><bold>0.9637</bold></td><td style="border:none;" align="center"><bold>0.3479</bold></td><td style="border:none;" align="center"><bold>0.9886</bold></td></tr><tr><td style="border:none;" align="left">128</td><td style="border:none;" align="center">0.9789</td><td style="border:none;" align="center">0.9656</td><td style="border:none;" align="center">0.9657</td><td style="border:none;" align="center">0.3480</td><td style="border:none;" align="center">0.9882</td></tr><tr><td style="border:none;" align="left">256</td><td style="border:none;" align="center">0.9789</td><td style="border:none;" align="center">0.9556</td><td style="border:none;" align="center">0.9557</td><td style="border:none;" align="center">0.3153</td><td style="border:none;" align="center">0.9875</td></tr><tr><td style="border:none;" align="left">512</td><td style="border:none;" align="center">0.9751</td><td style="border:none;" align="center">0.9582</td><td style="border:none;" align="center">0.9583</td><td style="border:none;" align="center">0.3216</td><td style="border:none;" align="center">0.9857</td></tr><tr><td style="border:none;" align="left">1024</td><td style="border:none;" align="center">0.9828</td><td style="border:none;" align="center">0.9546</td><td style="border:none;" align="center">0.9548</td><td style="border:none;" align="center">0.3206</td><td style="border:none;" align="center">0.9860</td></tr><tr><td style="border:none;" align="left">2048</td><td style="border:none;" align="center">0.9789</td><td style="border:none;" align="center">0.9486</td><td style="border:none;" align="center">0.9487</td><td style="border:none;" align="center">0.3082</td><td style="border:none;" align="center">0.9855</td></tr></tbody></table><table-wrap-foot><fn id="t4fn1"><label>a</label><p>The bolded row indicates the configuration
selected for the final model.</p></fn></table-wrap-foot></table-wrap><p>This filter size optimization, combined with the multiwindow strategy,
culminated in a robust and accurate calcium-binding site predictor.
Starting with a single-window approach (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, AUC 0.9796), we progressively improved
performance through the multiwindow strategy (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>, AUC 0.9860) and finally achieved peak performance
with the optimized filter size (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>, AUC 0.9886). These incremental gains, while seemingly
small, collectively represent a significant advancement in predictive
capability. The optimized filter size ensures the model learns generalizable
patterns from the data rather than memorizing specific examples, enhancing
the reliability of predictions on new sequences.</p><p>The true impact
of these optimizations becomes clear when compared
to existing state-of-the-art methods (<xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>). Our final model significantly outperforms these approaches,
validating the effectiveness of our design choices and demonstrating
the substantial contribution of each refinement step. This improved
performance provides researchers with a powerful new tool for investigating
calcium-binding proteins and their diverse biological functions, particularly
in the context of drug discovery.</p></sec><sec id="sec4.4"><title>The Performance Comparison
with Different Window Length</title><p>According to the data in <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>, the impact of different
window lengths on model performance
shows that the model achieved the best results with a window length
of 6 and an AUC value of 0.9886. As the window length increased, the
AUC generally decreased, suggesting that longer windows might introduce
redundant information, thereby diluting predictive features. This
finding suggests that calcium-binding site prediction should focus
more on specific, localized sequence features. Overly broad contextual
information may not only be unhelpful but possibly also interfere
with the model&#x02019;s ability to identify core features. Therefore,
determining an appropriate window length that maximizes the capture
of functionally relevant local sequence features while avoiding adding
unnecessary information is crucial for improving the model&#x02019;s
predictive accuracy.</p><table-wrap id="tbl5" position="float"><label>Table 5</label><caption><title>Performance Comparison
with Different
Splitting Window Length<xref rid="t5fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">window length</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>6</bold></td><td style="border:none;" align="center"><bold>0.9799</bold></td><td style="border:none;" align="center"><bold>0.9636</bold></td><td style="border:none;" align="center"><bold>0.9637</bold></td><td style="border:none;" align="center"><bold>0.3479</bold></td><td style="border:none;" align="center"><bold>0.9886</bold></td></tr><tr><td style="border:none;" align="left">7</td><td style="border:none;" align="center">0.9846</td><td style="border:none;" align="center">0.9443</td><td style="border:none;" align="center">0.9445</td><td style="border:none;" align="center">0.2863</td><td style="border:none;" align="center">0.9842</td></tr><tr><td style="border:none;" align="left">8</td><td style="border:none;" align="center">0.9549</td><td style="border:none;" align="center">0.9471</td><td style="border:none;" align="center">0.9471</td><td style="border:none;" align="center">0.2798</td><td style="border:none;" align="center">0.9780</td></tr><tr><td style="border:none;" align="left">9</td><td style="border:none;" align="center">0.9674</td><td style="border:none;" align="center">0.9434</td><td style="border:none;" align="center">0.9435</td><td style="border:none;" align="center">0.2766</td><td style="border:none;" align="center">0.9796</td></tr></tbody></table><table-wrap-foot><fn id="t5fn1"><label>a</label><p>The bolded
row indicates the configuration
selected for the final model.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec4.5"><title>The Performance Comparison with Different Features</title><p>In this
study, we selected ProtT5 from the ProtTrans series, specifically
ProtT5-XL-UniRef50, as the primary language model. This model was
pretrained on the UniRef50 data set, a nonredundant protein sequence
database provided by UniProt, where all sequences share less than
50% similarity. For ESM-2, we selected two models with different dimensions:
the 1280-dimensional model (esm2_t33_650M_UR50D) and the 2560-dimensional
model (esm2_t36_3B_UR50D). On the other hand, TAPE employed the Bert-based
model with a 768 dimension.</p><p>As shown in <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>, after 5-fold cross-validation and comparison,
ProtT5-XL-UniRef50 achieved the highest AUC (0.9886), demonstrating
the highest performance. It is worth noting that the higher-dimensional
ESM-2 model exhibited overfitting tendencies in the calcium ion binding
site prediction task, suggesting that larger models may not generalize
well to our data set. In contrast, the TAPE model, due to its smaller
dimension, achieved an AUC of only 0.9606, which was insufficient
in terms of accuracy. Ultimately, after extensive comparisons, ProtTrans
emerged as the best method for our study.</p><table-wrap id="tbl6" position="float"><label>Table 6</label><caption><title>Performance
Comparison with Different
Features<xref rid="t6fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">feature sets</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50</td><td style="border:none;" align="center"><bold>0.9799</bold></td><td style="border:none;" align="center"><bold>0.9636</bold></td><td style="border:none;" align="center"><bold>0.9637</bold></td><td style="border:none;" align="center"><bold>0.3479</bold></td><td style="border:none;" align="center"><bold>0.9886</bold></td></tr><tr><td style="border:none;" align="left">ESM-2-650M</td><td style="border:none;" align="center">0.9584</td><td style="border:none;" align="center">0.9655</td><td style="border:none;" align="center">0.9655</td><td style="border:none;" align="center">0.3564</td><td style="border:none;" align="center">0.9857</td></tr><tr><td style="border:none;" align="left">ESM-2-3B</td><td style="border:none;" align="center">0.9077</td><td style="border:none;" align="center">0.9314</td><td style="border:none;" align="center">0.9313</td><td style="border:none;" align="center">0.2677</td><td style="border:none;" align="center">0.9490</td></tr><tr><td style="border:none;" align="left">TAPE</td><td style="border:none;" align="center">0.9319</td><td style="border:none;" align="center">0.9138</td><td style="border:none;" align="center">0.9139</td><td style="border:none;" align="center">0.2104</td><td style="border:none;" align="center">0.9606</td></tr></tbody></table><table-wrap-foot><fn id="t6fn1"><label>a</label><p>The bolded row indicates the configuration
selected for the final model.</p></fn></table-wrap-foot></table-wrap><p>Next, we further analyzed the model&#x02019;s performance regarding
TP, FP, TN, and FN in independent tests. As shown in <xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>-a, ProtT5-XL-UniRef50 and TAPE had TP values of 26. ESM-2 (1280
and 2560 dimensions) achieved slightly higher TP values of 27. However,
the difference in TP between the four models was minimal. Notably,
the FP for ProtT5-XL-UniRef50 was only 80, which is 229 fewer than
ESM-2-650M, 393 less than ESM-2-3B, and 971 less than TAPE.</p><table-wrap id="tbl7" position="float"><label>Table 7</label><caption><title>Performance Comparison with Different
Features on the Testing Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">feature sets</th><th style="border:none;" align="center">TP</th><th style="border:none;" align="center">FP</th><th style="border:none;" align="center">TN</th><th style="border:none;" align="center">FN</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">80</td><td style="border:none;" align="center">3647</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td><td style="border:none;" align="center">0.9718</td></tr><tr><td style="border:none;" align="left">ESM-2-650M</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">309</td><td style="border:none;" align="center">3418</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.8710</td><td style="border:none;" align="center">0.9824</td><td style="border:none;" align="center">0.9815</td><td style="border:none;" align="center">0.4982</td><td style="border:none;" align="center">0.9627</td></tr><tr><td style="border:none;" align="left">ESM-2-3B</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">473</td><td style="border:none;" align="center">3254</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.9032</td><td style="border:none;" align="center">0.9230</td><td style="border:none;" align="center">0.9228</td><td style="border:none;" align="center">0.3330</td><td style="border:none;" align="center">0.9622</td></tr><tr><td style="border:none;" align="left">TAPE</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">1051</td><td style="border:none;" align="center">2676</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.7742</td><td style="border:none;" align="center">0.8298</td><td style="border:none;" align="center">0.8293</td><td style="border:none;" align="center">0.1467</td><td style="border:none;" align="center">0.8768</td></tr></tbody></table></table-wrap><fig id="fig5" position="float"><label>Figure 5</label><caption><p>(a) ROC curve for performance with different
features. (b) ROC
curve for performance with different imbalance-handling techniques.
(c) ROC curve for performance with different PCA dimensions. (d) ROC
curve for performance with merged features.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0005" id="gr5" position="float"/></fig><p>Although TP reflects the model&#x02019;s ability to correctly identify
binding sites, increasing TP often leads to an increase in FP. This
can be indirectly verified through changes in sensitivity and specificity.
When sensitivity increases, specificity decreases. An increase in
FP implies higher resource demands during drug development.</p></sec><sec id="sec4.6"><title>The Performance
Comparison with Different Imbalance-Handling
Techniques on the Testing Data Set</title><p>Considering the significant
imbalance between positive and negative samples in the initial data
set, capturing true positives and balancing the reduction of false
positives becomes particularly crucial in such data sets. We applied
additional imbalance treatments to the data set and compared the results
with the original method. The imbalance treatment methods included
SMOTE,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> ADASYN,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> and Random Oversampling.</p><p>As shown in <xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>-b, imbalance treatments improved sensitivity to some
extent (e.g., ADASYN increased sensitivity from 0.8387 to 0.8710 in
the test set). However, this was often accompanied by a significant
increase in FP, as well as a decrease in specificity and MCC. For
example, ADASYN resulted in an FP of 330, a drop in specificity to
0.9115, and a decrease in MCC to 0.2414. This &#x0201c;increase in
TP at the expense of specificity&#x0201d; is particularly detrimental
to drug development, as each false positive could become a false target
during subsequent experimental stages, leading to unnecessary resource
investment and wasted manpower. To achieve a balance between TP and
specificity while maintaining model stability and preventing overfitting,
we selected the original method as the final version.</p><table-wrap id="tbl8" position="float"><label>Table 8</label><caption><title>Performance Comparison with Different
Imbalance-Handling Techniques on the Testing Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">imbalance-handling</th><th style="border:none;" align="center">TP</th><th style="border:none;" align="center">FP</th><th style="border:none;" align="center">TN</th><th style="border:none;" align="center">FN</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">original</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">80</td><td style="border:none;" align="center">3647</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td><td style="border:none;" align="center">0.9718</td></tr><tr><td style="border:none;" align="left">SMOTE</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">178</td><td style="border:none;" align="center">3549</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9522</td><td style="border:none;" align="center">0.9513</td><td style="border:none;" align="center">0.3157</td><td style="border:none;" align="center">0.9638</td></tr><tr><td style="border:none;" align="left">ADASYN</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">330</td><td style="border:none;" align="center">3397</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.8710</td><td style="border:none;" align="center">0.9115</td><td style="border:none;" align="center">0.9111</td><td style="border:none;" align="center">0.2414</td><td style="border:none;" align="center">0.9638</td></tr><tr><td style="border:none;" align="left">random oversampling</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">182</td><td style="border:none;" align="center">3545</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9512</td><td style="border:none;" align="center">0.9502</td><td style="border:none;" align="center">0.3124</td><td style="border:none;" align="center">0.9514</td></tr></tbody></table></table-wrap><p>The original method maintained a better balance between
FP and
TP, avoiding overoptimization of TP at the expense of specificity
and model generalization. We believe that increasing only TP while
ignoring FP is not appropriate in drug screening. On the contrary,
maintaining relatively high specificity ensures that the model focuses
more on biologically significant binding sites. This prevents nonfunctional
residues from being misclassified as calcium-binding sites. This approach
helps concentrate efforts on high-quality targets during subsequent
drug development stages, further improving development efficiency.</p></sec><sec id="sec4.7"><title>The Performance Comparison with Different PCA Dimensions on
the Testing Data Set</title><p>In the previous discussion, we noted
that ProtTrans achieves a more stable trade-off between &#x0201c;enhancing
sensitivity&#x0201d; and &#x0201c;maintaining high specificity.&#x0201d;
In light of this, our subsequent dimensionality reduction experiments
focused on the ProtT5-XL-UniRef50 model.</p><p>We performed PCA on
the original 1024-dimensional ProtTrans vectors, reducing them to
64, 128, 256, 512, and retaining the initial 1024 dimensions. Our
aim was to investigate whether it was possible to lower computational
complexity, speed up training, or achieve better generalization. This
was without losing too much critical information. According to <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>(c), while reducing dimensions
causes minimal changes in TP, FP fluctuates considerably, and overall
performance also varies significantly. Although using fewer dimensions
requires fewer resources than the original 1024 dimensions, predictive
accuracy (AUC) drops noticeably from 0.9718 to 0.9380.</p><table-wrap id="tbl9" position="float"><label>Table 9</label><caption><title>Performance Comparison with Different
PCA Dimensions on the Testing Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">dimension</th><th style="border:none;" align="center">TP</th><th style="border:none;" align="center">FP</th><th style="border:none;" align="center">TN</th><th style="border:none;" align="center">FN</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">original (1024)</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">80</td><td style="border:none;" align="center">3647</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td><td style="border:none;" align="center">0.9718</td></tr><tr><td style="border:none;" align="left">64</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">264</td><td style="border:none;" align="center">3463</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9292</td><td style="border:none;" align="center">0.9284</td><td style="border:none;" align="center">0.2603</td><td style="border:none;" align="center">0.9380</td></tr><tr><td style="border:none;" align="left">128</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">149</td><td style="border:none;" align="center">3578</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">0.8065</td><td style="border:none;" align="center">0.9600</td><td style="border:none;" align="center">0.9588</td><td style="border:none;" align="center">0.3299</td><td style="border:none;" align="center">0.9333</td></tr><tr><td style="border:none;" align="left">256</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">314</td><td style="border:none;" align="center">3413</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9157</td><td style="border:none;" align="center">0.9151</td><td style="border:none;" align="center">0.2379</td><td style="border:none;" align="center">0.9471</td></tr><tr><td style="border:none;" align="left">512</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">196</td><td style="border:none;" align="center">3531</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">0.8065</td><td style="border:none;" align="center">0.9474</td><td style="border:none;" align="center">0.9462</td><td style="border:none;" align="center">0.2898</td><td style="border:none;" align="center">0.9458</td></tr></tbody></table></table-wrap><p>Although
dimensionality reduction can indeed reduce computational
overhead and overfitting risk, in our study, balancing TP and specificity
is pivotal for drug development. Sacrificing specificity to raise
TP is particularly disadvantageous for drug discovery, as more false
positives can lead to resource wastage and reduce overall predictive
accuracy, introducing extra costs and unnecessary directions for subsequent
screening and experiments.</p><p>Therefore, to achieve higher predictive
accuracy and balance, the
original 1024-dimensional ProtTrans still delivers better performance.</p></sec><sec id="sec4.8"><title>The Performance Comparison with Merged Features on the Testing
Data Set</title><p>In terms of model merging, considering that the
1280-dimensional ESM-2 model performs better than the 2560-dimensional
version, we chose to use ESM-2-650M as the basis for comparison. We
combined ProtT5-XL-UniRef50 with the other two embedded models, resulting
in four combinations: (ProtT5-XL-UniRef50+ESM-2-650M), (ProtT5-XL-UniRef50+TAPE),
(ESM-2-650M+TAPE), and (ProtT5-XL-UniRef50+ESM-2-650M+TAPE).</p><p>As shown in <xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref> and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>-d, while
these combinations slightly improve sensitivity in certain cases,
they also significantly increase false positive rates. Although merging
embeddings allows the model to capture more contextual information
from sequences, it also introduces additional noise, resulting in
reduced predictive accuracy. As mentioned in our discussion of ProtTrans
advantages, an increase in TP often brings higher FP. While accurately
predicting calcium-binding sites is crucial, an increase in FP indicates
a higher likelihood of misclassification, leading to increased resource
wastage and negatively impacting the model&#x02019;s generalization
ability.</p><table-wrap id="tbl10" position="float"><label>Table 10</label><caption><title>Performance Comparison with Merged
Features on the Testing Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">feature sets</th><th style="border:none;" align="center">dimension</th><th style="border:none;" align="center">TP</th><th style="border:none;" align="center">FP</th><th style="border:none;" align="center">TN</th><th style="border:none;" align="center">FN</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50</td><td style="border:none;" align="center">1024</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">80</td><td style="border:none;" align="center">3647</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td><td style="border:none;" align="center">0.9718</td></tr><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50+ESM-2-650M</td><td style="border:none;" align="center">2304</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">211</td><td style="border:none;" align="center">3516</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.8710</td><td style="border:none;" align="center">0.9434</td><td style="border:none;" align="center">0.9428</td><td style="border:none;" align="center">0.3024</td><td style="border:none;" align="center">0.9636</td></tr><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50+TAPE</td><td style="border:none;" align="center">1792</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">322</td><td style="border:none;" align="center">3405</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.8710</td><td style="border:none;" align="center">0.9136</td><td style="border:none;" align="center">0.9133</td><td style="border:none;" align="center">0.2445</td><td style="border:none;" align="center">0.9523</td></tr><tr><td style="border:none;" align="left">ESM-2-650M+TAPE</td><td style="border:none;" align="center">2048</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">263</td><td style="border:none;" align="center">3464</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9294</td><td style="border:none;" align="center">0.9287</td><td style="border:none;" align="center">0.2608</td><td style="border:none;" align="center">0.9543</td></tr><tr><td style="border:none;" align="left">ProtT5-XL-UniRef50+ESM-2-650M+TAPE</td><td style="border:none;" align="center">3072</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">308</td><td style="border:none;" align="center">3419</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">0.8710</td><td style="border:none;" align="center">0.9174</td><td style="border:none;" align="center">0.9170</td><td style="border:none;" align="center">0.2502</td><td style="border:none;" align="center">0.9442</td></tr></tbody></table></table-wrap><p>In this study, we emphasize the balance between
TP and FP. The
original ProtTrans embedding maintains the highest overall balance
among all performance indicators, particularly in terms of AUC (0.9718)
and MCC (0.4465). Therefore, ProtTrans alone emerges as our optimal
choice.</p></sec><sec id="sec4.9"><title>The Performance Comparison with Different Classifiers On The
Testing Data Set</title><p><xref rid="tbl11" ref-type="other">Table <xref rid="tbl11" ref-type="other">11</xref></xref> and <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref> compare mCNN&#x02019;s performance with various deep learning
and classification models. The TP (True Positive) values for KNN,
SVM, RF, and XGBoost were 14, 11, 4, and 6, respectively, while their
specificity values were 0.9987, 0.9984, 0.9995, and 0.9995. Although
these models demonstrated excellent specificity (particularly RF and
XGBoost, with specificity nearing 0.9995), their sensitivity was generally
low, resulting in the inability to effectively detect real binding
sites. RF and XGBoost achieved TP values of only 4 and 6, indicating
their limited ability to recognize true binding sites. In drug target
discovery, insufficient sensitivity may cause the model to miss many
true positive cases. This may lead to overlooking critical binding
sites and negatively impact drug development.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>ROC curve for performance
with different machine learning models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0006" id="gr6" position="float"/></fig><table-wrap id="tbl11" position="float"><label>Table 11</label><caption><title>Performance Comparison with Different
Classifiers on the Testing Data Set</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">model</th><th style="border:none;" align="center">TP</th><th style="border:none;" align="center">FP</th><th style="border:none;" align="center">TN</th><th style="border:none;" align="center">FN</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">KNN</td><td style="border:none;" align="center">14</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">3722</td><td style="border:none;" align="center">17</td><td style="border:none;" align="center">0.4516</td><td style="border:none;" align="center">0.9987</td><td style="border:none;" align="center">0.9941</td><td style="border:none;" align="center">0.5742</td><td style="border:none;" align="center">0.8358</td></tr><tr><td style="border:none;" align="left">SVM</td><td style="border:none;" align="center">11</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">3721</td><td style="border:none;" align="center">20</td><td style="border:none;" align="center">0.3548</td><td style="border:none;" align="center">0.9984</td><td style="border:none;" align="center">0.9931</td><td style="border:none;" align="center">0.4761</td><td style="border:none;" align="center">0.9474</td></tr><tr><td style="border:none;" align="left">RF</td><td style="border:none;" align="center">4</td><td style="border:none;" align="center">2</td><td style="border:none;" align="center">3725</td><td style="border:none;" align="center">27</td><td style="border:none;" align="center">0.1290</td><td style="border:none;" align="center">0.9995</td><td style="border:none;" align="center">0.9923</td><td style="border:none;" align="center">0.2911</td><td style="border:none;" align="center">0.7924</td></tr><tr><td style="border:none;" align="left">XGBoost</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">2</td><td style="border:none;" align="center">3725</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">0.1935</td><td style="border:none;" align="center">0.9995</td><td style="border:none;" align="center">0.9928</td><td style="border:none;" align="center">0.3788</td><td style="border:none;" align="center">0.9167</td></tr><tr><td style="border:none;" align="left">CNN</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">403</td><td style="border:none;" align="center">3324</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">0.8065</td><td style="border:none;" align="center">0.8919</td><td style="border:none;" align="center">0.8912</td><td style="border:none;" align="center">0.1988</td><td style="border:none;" align="center">0.8684</td></tr><tr><td style="border:none;" align="left">transformer</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">517</td><td style="border:none;" align="center">3210</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">0.8065</td><td style="border:none;" align="center">0.8613</td><td style="border:none;" align="center">0.8608</td><td style="border:none;" align="center">0.1719</td><td style="border:none;" align="center">0.8869</td></tr><tr><td style="border:none;" align="left">LSTM</td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">360</td><td style="border:none;" align="center">3367</td><td style="border:none;" align="center">6</td><td style="border:none;" align="center">0.8065</td><td style="border:none;" align="center">0.9034</td><td style="border:none;" align="center">0.9026</td><td style="border:none;" align="center">0.2117</td><td style="border:none;" align="center">0.9227</td></tr><tr><td style="border:none;" align="left">mCNN</td><td style="border:none;" align="center">26</td><td style="border:none;" align="center">80</td><td style="border:none;" align="center">3647</td><td style="border:none;" align="center">5</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td><td style="border:none;" align="center">0.9718</td></tr></tbody></table></table-wrap><p>Compared
to the four models mentioned above, CNN, Transformer,
and LSTM significantly improved sensitivity and TP. However, this
often came at the cost of higher FP. However, mCNN demonstrated significant
advantages by achieving the highest TP (26) and substantially reducing
FP (80) among all models. mCNN not only accurately identified calcium-binding
sites but also effectively reduced the false positive rate for noncalcium-binding
sites. An increase in TP indicates that the model can more precisely
locate calcium-binding sites, while a reduction in FP minimizes the
risk of misidentifying irrelevant sites as targets during drug screening
and development, ultimately saving resources and improving drug development
success rates.</p><p>In summary, compared to other models, mCNN validates
features more
effectively through its multiwindow design, capturing sequence features
at different scales and avoiding information loss from single-window
approaches. This feature extraction method enhances overall predictive
accuracy, making the model more adaptable when dealing with complex
and diverse protein sequences. It can identify more potential calcium-binding
sites while minimizing false positives, thereby supporting the development
of CCB drugs.</p></sec><sec id="sec4.10"><title>The Performance Comparison with Previous
Works</title><p>We compared
its performance against four existing calcium-binding site prediction
methods: DELIA,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> GraphBind,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> MIB2,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> and SCAMPER.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> DELIA uses a hybrid deep learning approach combining
1D sequence and 2D structural information, employing techniques like
oversampling and undersampling to address imbalanced data sets. DELIA
effectively integrates sequence and structural information and addresses
data set imbalances; however, it struggles to capture global sequence
patterns and may miss diverse binding sites due to its focus on local
features. GraphBind leverages graph neural networks (GNNs), converting
protein structures into graphs and using hierarchical GNNs to incorporate
structural and physicochemical features. GraphBind excels at capturing
structural motifs and physicochemical properties. However, its sensitivity
to diverse binding sites is limited due to a pronounced bias toward
specific structural motifs. MIB2 employs a fragment transformation
method, comparing query protein regions to template structures from
a metal ion-binding database. MIB2 effectively matches query regions
to template structures but is constrained by the template database,
potentially failing to identify novel or uncommon binding sites. SCAMPER
utilizes a two-layer architecture, processing sequence data from the
BioLip and UniProt databases and aiming to minimize cross-prediction
errors between different interacting residue types. SCAMPER reduces
cross-prediction errors and leverages large sequence databases; however,
it may struggle with complex structural contexts and is highly dependent
on input data quality.</p><p>CaBind_MCNN integrates embeddings from
pretrained protein language models (pLMs) such as ProtTrans, ESM-2,
and TAPE. These embeddings capture rich contextual information from
protein sequences, providing comprehensive protein feature representations.
This enhances the model&#x02019;s ability to identify calcium-binding
sites with high sensitivity and specificity. CaBind_MCNN employs a
multiwindow convolutional neural network (mCNN) architecture, scanning
protein sequences with variable-scale windows. This multiscale approach
allows the model to capture both local and global sequence patterns.
By integrating pLM embeddings, CaBind_MCNN leverages advanced feature
representations and a robust model architecture, resulting in superior
performance across various evaluation metrics.</p><p>As shown in <xref rid="tbl12" ref-type="other">Table <xref rid="tbl12" ref-type="other">12</xref></xref>, all models were
evaluated based on a testing data set containing
31 calcium-binding residues and 3727 non binding residues, as well
as sensitivity, specificity, accuracy, and Matthews Correlation Coefficient
(MCC).</p><table-wrap id="tbl12" position="float"><label>Table 12</label><caption><title>Performance Comparison with Previous
Methods</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">methods</th><th style="border:none;" align="center">years</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th></tr></thead><tbody><tr><td style="border:none;" align="left">DELIA<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></td><td style="border:none;" align="center">2020</td><td style="border:none;" align="center">0.3548</td><td style="border:none;" align="center">0.9995</td><td style="border:none;" align="center">0.9941</td><td style="border:none;" align="center">0.5458</td></tr><tr><td style="border:none;" align="left">Graphbind<sup><xref ref-type="bibr" rid="ref24">24</xref></sup></td><td style="border:none;" align="center">2021</td><td style="border:none;" align="center">0.0968</td><td style="border:none;" align="center">0.9987</td><td style="border:none;" align="center">0.9912</td><td style="border:none;" align="center">0.1538</td></tr><tr><td style="border:none;" align="left">MIB2<sup><xref ref-type="bibr" rid="ref31">31</xref></sup></td><td style="border:none;" align="center">2022</td><td style="border:none;" align="center">0.7097</td><td style="border:none;" align="center">0.8868</td><td style="border:none;" align="center">0.8853</td><td style="border:none;" align="center">0.1671</td></tr><tr><td style="border:none;" align="left">SCAMPER<sup><xref ref-type="bibr" rid="ref25">25</xref></sup></td><td style="border:none;" align="center">2023</td><td style="border:none;" align="center">0.2581</td><td style="border:none;" align="center">0.8887</td><td style="border:none;" align="center">0.0194</td><td style="border:none;" align="center">0.0425</td></tr><tr><td style="border:none;" align="left">CaBind_MCNN</td><td style="border:none;" align="center">2024</td><td style="border:none;" align="center">0.8387</td><td style="border:none;" align="center">0.9785</td><td style="border:none;" align="center">0.9774</td><td style="border:none;" align="center">0.4465</td></tr></tbody></table></table-wrap><p>CaBind_MCNN achieved a sensitivity
of 0.8387, significantly outperforming
the other methods (DELIA: 0.3548, GraphBind: 0.0968, MIB2:0.7097,
SCAMPER: 0.2581). Given the highly imbalanced nature of the data set,
prioritizing sensitivity is crucial for effective calcium-binding
site prediction. High sensitivity is essential for identifying the
relatively rare true binding sites, paramount for downstream applications
like CCB drug target identification. While CaBind_MCNN maintains high
specificity (0.9785), its substantial sensitivity advantage underscores
its effectiveness.</p><p>Despite exhibiting high specificity (0.9995),
accuracy (0.9941),
and MCC (0.5458), DELIA&#x02019;s comparatively low sensitivity (0.3548)
limits its practical utility. Its strategies for handling imbalanced
data, while potentially beneficial for overall performance, may sacrifice
the ability to capture a significant portion of true binding sites.
GraphBind, despite similar high specificity (0.9987) and accuracy
(0.9912), also suffers from extremely low sensitivity (0.0968). This
suggests its graph-based approach may not effectively capture relevant
binding features. MIB2, with a sensitivity of 0.7097, performs better
than DELIA and GraphBind but remains inferior to CaBind_MCNN. Its
template-based approach may struggle with proteins exhibiting novel
structures or significant deviations from known templates. SCAMPER
shows considerably lower performance across all metrics, including
very low sensitivity (0.2581) and accuracy (0.0194), indicating limitations
in its predictive capabilities.</p><p>Furthermore, CaBind_MCNN demonstrated
a balanced approach, effectively
identifying binding sites across diverse structural contexts without
overly relying on specific structural features. In contrast, GraphBind
showed a pronounced bias toward certain structural motifs, resulting
in lower sensitivity. While DELIA and MIB2 exhibited more balanced
performance, they still fell short of capturing the full spectrum
of true binding sites compared to CaBind_MCNN. This comprehensive
performance across varied structural scenarios highlights CaBind_MCNN&#x02019;s
robustness and adaptability to calcium-binding site prediction.</p><p>Our emphasis on sensitivity reflects the specific demands of calcium-binding
site prediction for drug discovery. While CaBind_MCNN&#x02019;s MCC
(0.4465) is slightly lower than DELIA&#x02019;s, the substantial gain
in sensitivity is a worthwhile trade-off. Accurately identifying true
binding sites, even at the cost of a marginal increase in false positives
(and a slightly lower MCC), is crucial for effective drug target identification.
This focus on sensitivity reinforces CaBind_MCNN&#x02019;s practical
value in accelerating the discovery of potential CCB drug targets.</p></sec><sec id="sec4.11"><title>Enhanced Validation Using a ChEMBL Data Set of CCB Targets</title><p>To further validate our model and address potential concerns about
the initial data set size, we curated a new data set from the ChEMBL
database<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> focusing on calcium channel
blockers (CCBs)<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> and their protein targets.
Starting with a search for &#x0201c;Calcium Channel Blocker,&#x02033;
we identified 315 related proteins. We then filtered this set to include
only proteins with annotated binding sites, resulting in 50 proteins.
We used CD-HIT with a 40% similarity threshold to process the data
against the training set, preventing overfitting caused by overly
similar data. This resulted in a data set containing 23 calcium ion
channel protein sequences. The data set includes 23,817 residues,
of which 177 are calcium-binding sites and 23,640 are nonbinding sites.</p><p>This ChEMBL-derived data set offers several advantages. Given that
CCBs like Nitrendipine and Diltiazem primarily target L-type calcium
channels, focusing on CCB-interacting proteins increases the pharmacological
relevance of our validation. By accurately predicting calcium-binding
sites within these proteins, we aimed to improve the model&#x02019;s
ability to identify potential drug targets and facilitate the development
of more effective CCBs. For example, the data set includes proteins
like the L-type calcium channel Q13936, enabling analysis of its binding
interactions and contributing to a deeper understanding of the structural
features essential for drug binding and channel inhibition.</p><p>As shown in <xref rid="tbl13" ref-type="other">Table <xref rid="tbl13" ref-type="other">13</xref></xref> and <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>, our
model achieved a sensitivity of 0.8644 on this ChEMBL data set, demonstrating
its ability to accurately predict calcium-binding sites in pharmacologically
relevant calcium ion channels. This high sensitivity underscores the
model&#x02019;s potential to accelerate CCB drug discovery. While the
MCC is relatively low, our primary focus remains sensitivity because
the interaction of CCBs with calcium-binding sites is paramount for
drug target identification. This refined data set allows for a more
accurate and contextually relevant assessment of our model&#x02019;s
ability to predict calcium-binding sites, leading to a deeper understanding
of calcium ion-protein interactions and potentially facilitating the
design of more targeted and effective CCB drugs.</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>ROC curve for the performance
of predicting calcium interacting
residues from calcium channel with the ChEMBL data set.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci4c02252_0007" id="gr7" position="float"/></fig><table-wrap id="tbl13" position="float"><label>Table 13</label><caption><title>Enhanced Validation Using a ChEMBL
Data Set of CCB Targets</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead><tr><th style="border:none;" align="center">data set</th><th style="border:none;" align="center">sensitivity</th><th style="border:none;" align="center">specificity</th><th style="border:none;" align="center">accuracy</th><th style="border:none;" align="center">MCC</th><th style="border:none;" align="center">AUC</th></tr></thead><tbody><tr><td style="border:none;" align="left">independent test with ChEMBL data set</td><td style="border:none;" align="center">0.8644</td><td style="border:none;" align="center">0.8934</td><td style="border:none;" align="center">0.8932</td><td style="border:none;" align="center">0.2062</td><td style="border:none;" align="center">0.9319</td></tr></tbody></table></table-wrap></sec></sec><sec id="sec5"><title>Conclusion</title><p>In this study, we present a new computational model called CaBind_MCNN,
designed to identify calcium-binding sites within ion channels and
transporter proteins. By combining protein language models (PLMs)
with multiscale feature extraction methods, our model has demonstrated
outstanding performance in predicting calcium-binding sites, achieving
a high AUC of 0.9886. This exceptional predictive capability significantly
surpasses traditional methods, highlighting the immense potential
of our model in both basic research and practical drug discovery.</p><p>There are significant practical implications to our findings. Calcium
ions play a crucial role in various physiological processes. Dysregulation
of calcium homeostasis is closely associated with several serious
health issues, including arrhythmias, hypertension, and other cardiovascular
diseases. Ion channels and transporter proteins are key to maintaining
intracellular calcium ion balance, and disruption in the function
of these proteins can lead to severe pathological conditions. Our
model&#x02019;s ability to accurately predict calcium-binding sites
in these proteins provides a powerful tool for understanding the molecular
mechanisms underlying these diseases.</p><p>Moreover, the current
limitations of existing calcium channel blockers
(CCBs) in clinical practice further highlight the relevance of our
work. While CCBs have been effective in treating various cardiovascular
conditions, their use is often limited by side effects, such as hypotension,
dizziness, and reduced cardiac contraction which can be particularly
detrimental in patients with heart failure. Additionally, the interaction
of CCBs with other medications can lead to adverse outcomes, such
as excessive bradycardia and atrioventricular conduction block. These
challenges underscore the need for improved, more selective, and safer
CCBs.</p><p>The CaBind_MCNN model holds significant promise in addressing
these
challenges. By accurately identifying calcium-binding sites, our model
can facilitate the discovery of novel drug targets, potentially leading
to the development of innovative CCBs that are more effective and
have fewer side effects. This could include the design of medications
specific to certain calcium channel subtypes or the optimization of
existing CCBs to enhance their therapeutic profile. The insights gained
from our model could also contribute to a deeper understanding of
the mechanisms of action of current medications, enabling the refinement
of existing therapies to better meet patient needs.<list list-type="simple"><title>Key Points</title><list-item><label>1.</label><p>CaBind_MCNN identifies potential CCB
targets: The model predicts Ca<sup>2+</sup> binding sites in ion channels
and transporter proteins, highlighting potential targets for novel
CCB development.</p></list-item><list-item><label>2.</label><p>Leverages
advanced protein language
models: CaBind_MCNN utilizes ProtTrans, a powerful PLM, to generate
enriched sequence representations capturing crucial contextual information
for accurate binding site prediction.</p></list-item><list-item><label>3.</label><p>Employs multiscale feature extraction:
The multiwindow scanning approach of CaBind_MCNN effectively captures
local and global sequence features relevant to Ca<sup>2+</sup> binding,
improving prediction accuracy.</p></list-item><list-item><label>4.</label><p>Outperforms existing methods: CaBind_MCNN
achieves a high AUC of 0.9886, surpassing existing Ca<sup>2+</sup> binding site prediction methods, particularly in sensitivity.</p></list-item><list-item><label>5.</label><p>Facilitates drug discovery
for calcium-related
disorders: By identifying potential CCB targets, CaBind_MCNN can accelerate
the development of novel therapies for diseases linked to Ca<sup>2+</sup> dysregulation, such as arrhythmias and hypertension.</p></list-item></list></p></sec></body><back><notes notes-type="data-availability" id="notes3"><title>Data Availability Statement</title><p>In addition,
the code and data for this work are available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/B1607/CaBind_MCNN">https://github.com/B1607/CaBind_MCNN</uri></p></notes><notes notes-type="" id="notes4"><title>Author Contributions</title><p>Y.-Y.C.:
conceptualization,
software, validation, formal analysis, data curation, writing&#x02014;original
draft. Y.-C.L.: software, validation, formal analysis, data curation,
writing&#x02014;original draft. W.E.J.: software, validation, data
curation, writing&#x02014;original draft. S.-S.W.: software, validation,
data curation, writing&#x02014;original draft. Y.-Y.O.: conceptualization,
methodology, resources, writing&#x02014;reviewing and editing, supervision</p></notes><notes notes-type="COI-statement" id="notes2"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This work was partially supported by the National
Science and Technology Council, Taiwan under Grant No. NSTC 112-2221-E-155-020-MY3.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Augustine</surname><given-names>G. J.</given-names></name>
<article-title>How does
calcium trigger neurotransmitter release?</article-title>. <source>Current
opinion in neurobiology</source>
<year>2001</year>, <volume>11</volume> (<issue>3</issue>), <fpage>320</fpage>&#x02013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/S0959-4388(00)00214-2</pub-id>.<pub-id pub-id-type="pmid">11399430</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>S&#x000fc;dhof</surname><given-names>T. C.</given-names></name>
<article-title>Calcium
control of neurotransmitter release</article-title>. <source>Cold Spring
Harbor perspectives in biology</source>
<year>2012</year>, <volume>4</volume> (<issue>1</issue>), <fpage>a011353</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a011353</pub-id>.<pub-id pub-id-type="pmid">22068972</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Cannell</surname><given-names>M. B.</given-names></name>; <name><surname>Cheng</surname><given-names>H.</given-names></name>; <name><surname>Lederer</surname><given-names>W. J.</given-names></name>
<article-title>The control of calcium
release in
heart muscle</article-title>. <source>Science</source>
<year>1995</year>, <volume>268</volume> (<issue>5213</issue>), <fpage>1045</fpage>&#x02013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1126/science.7754384</pub-id>.<pub-id pub-id-type="pmid">7754384</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Eisner</surname><given-names>D.</given-names></name>
<article-title>Calcium in
the heart: from physiology to disease</article-title>. <source>Experimental
physiology</source>
<year>2014</year>, <volume>99</volume> (<issue>10</issue>), <fpage>1273</fpage>&#x02013;<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.2013.077305</pub-id>.<pub-id pub-id-type="pmid">25128325</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Eisner</surname><given-names>D. A.</given-names></name>; et al. <article-title>Calcium and excitation-contraction
coupling in the heart</article-title>. <source>Circulation research</source>
<year>2017</year>, <volume>121</volume> (<issue>2</issue>), <fpage>181</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310230</pub-id>.<pub-id pub-id-type="pmid">28684623</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Conte
Camerino</surname><given-names>D.</given-names></name>; <name><surname>Tricarico</surname><given-names>D.</given-names></name>; <name><surname>Desaphy</surname><given-names>J.-F.</given-names></name>
<article-title>Ion channel pharmacology</article-title>. <source>Neurotherapeutics</source>
<year>2007</year>, <volume>4</volume>, <fpage>184</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/j.nurt.2007.01.013</pub-id>.<pub-id pub-id-type="pmid">17395128</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Jentsch</surname><given-names>T. J.</given-names></name>; <name><surname>H&#x000fc;bner</surname><given-names>C. A.</given-names></name>; <name><surname>Fuhrmann</surname><given-names>J. C.</given-names></name>
<article-title>Ion channels: function
unravelled
by dysfunction</article-title>. <source>Nature cell biology</source>
<year>2004</year>, <volume>6</volume> (<issue>11</issue>), <fpage>1039</fpage>&#x02013;<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1104-1039</pub-id>.<pub-id pub-id-type="pmid">15516997</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>DeFelice</surname><given-names>L. J.</given-names></name>; <name><surname>Goswami</surname><given-names>T.</given-names></name>
<article-title>Transporters as channels</article-title>. <source>Annu.
Rev. Physiol.</source>
<year>2007</year>, <volume>69</volume> (<issue>1</issue>), <fpage>87</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.031905.164816</pub-id>.<pub-id pub-id-type="pmid">17059369</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Le</surname><given-names>V.-T.</given-names></name>; et al. <article-title>DeepPLM_mCNN: An approach
for enhancing ion channel and ion transporter
recognition by multi-window CNN based on features from pre-trained
language models</article-title>. <source>Computational Biology and Chemistry</source>
<year>2024</year>, <volume>110</volume>, <fpage>108055</fpage><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2024.108055</pub-id>.<pub-id pub-id-type="pmid">38555810</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Taju</surname><given-names>S. W.</given-names></name>; <name><surname>Ou</surname><given-names>Y. Y.</given-names></name>
<article-title>DeepIon: Deep learning
approach for classifying ion transporters
and ion channels from membrane proteins</article-title>. <source>J.
Comput. Chem.</source>
<year>2019</year>, <volume>40</volume> (<issue>15</issue>), <fpage>1521</fpage>&#x02013;<lpage>1529</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.25805</pub-id>.<pub-id pub-id-type="pmid">30883833</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Giladi</surname><given-names>M.</given-names></name>; et al. <article-title>Structure-functional basis of ion transport in sodium&#x02013;calcium
exchanger (NCX) proteins</article-title>. <source>International journal
of molecular sciences</source>
<year>2016</year>, <volume>17</volume> (<issue>11</issue>), <fpage>1949</fpage><pub-id pub-id-type="doi">10.3390/ijms17111949</pub-id>.<pub-id pub-id-type="pmid">27879668</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Khananshvili</surname><given-names>D.</given-names></name>
<article-title>The SLC8 gene
family of sodium&#x02013;calcium exchangers (NCX)&#x02013;Structure,
function, and regulation in health and disease</article-title>. <source>Molecular aspects of medicine</source>
<year>2013</year>, <volume>34</volume> (<issue>2&#x02013;3</issue>), <fpage>220</fpage>&#x02013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2012.07.003</pub-id>.<pub-id pub-id-type="pmid">23506867</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Edwards</surname><given-names>S. L.</given-names></name>; <name><surname>Pgcea</surname><given-names>D.</given-names></name>; <name><surname>Edwards</surname><given-names>A. T.</given-names></name>
<article-title>Maintaining
calcium balance: physiology
and implications</article-title>. <source>Medicine</source>
<year>2005</year>, <volume>328</volume>, <fpage>833</fpage>&#x02013;<lpage>838</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Mark</surname><given-names>M. D.</given-names></name>; et al. <article-title>Keeping our calcium in balance to maintain our balance</article-title>. <source>Biochemical and biophysical research communications</source>
<year>2017</year>, <volume>483</volume> (<issue>4</issue>), <fpage>1040</fpage>&#x02013;<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.07.020</pub-id>.<pub-id pub-id-type="pmid">27392710</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="book" id="cit15"><person-group person-group-type="allauthors"><name><surname>Rajagopal</surname><given-names>S.</given-names></name></person-group>; <etal/><article-title>Calcium ion in biological systems</article-title>. <source>Calcium
Signaling: From Physiology to Diseases</source>; <publisher-name>Springer</publisher-name>: <publisher-loc>Singapore</publisher-loc>, <year>2017</year>; p <fpage>1</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1007/978-981-10-5160-9_1</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name>; <name><surname>Burashnikov</surname><given-names>A.</given-names></name>
<article-title>Overview of basic mechanisms of cardiac
arrhythmia</article-title>. <source>Cardiac electrophysiology clinics</source>
<year>2011</year>, <volume>3</volume> (<issue>1</issue>), <fpage>23</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2010.10.012</pub-id>.<pub-id pub-id-type="pmid">21892379</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Kistamas</surname><given-names>K.</given-names></name>; <name><surname>Veress</surname><given-names>R.</given-names></name>; <name><surname>Horvath</surname><given-names>B.</given-names></name>; <name><surname>Banyasz</surname><given-names>T.</given-names></name>; <name><surname>Nanasi</surname><given-names>P. P.</given-names></name>; <name><surname>Eisner</surname><given-names>D. A.</given-names></name>
<article-title>Calcium handling defects and cardiac arrhythmia syndromes</article-title>. <source>Front. Pharmacol.</source>
<year>2020</year>, <volume>11</volume>, <fpage>72</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.00072</pub-id>.<pub-id pub-id-type="pmid">32161540</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Scoote</surname><given-names>M.</given-names></name>; <name><surname>Williams</surname><given-names>A. J.</given-names></name>
<article-title>Myocardial calcium signalling and arrhythmia pathogenesis</article-title>. <source>Biochemical and biophysical research communications</source>
<year>2004</year>, <volume>322</volume> (<issue>4</issue>), <fpage>1286</fpage>&#x02013;<lpage>1309</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.08.034</pub-id>.<pub-id pub-id-type="pmid">15336976</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Landstrom</surname><given-names>A. P.</given-names></name>; <name><surname>Dobrev</surname><given-names>D.</given-names></name>; <name><surname>Wehrens</surname><given-names>X. H. T.</given-names></name>
<article-title>Calcium signaling and cardiac arrhythmias</article-title>. <source>Circulation research</source>
<year>2017</year>, <volume>120</volume> (<issue>12</issue>), <fpage>1969</fpage>&#x02013;<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310083</pub-id>.<pub-id pub-id-type="pmid">28596175</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Shah</surname><given-names>K.</given-names></name>; et al. <article-title>Calcium channels in
the heart: disease states and drugs</article-title>. <source>Cells</source>
<year>2022</year>, <volume>11</volume> (<issue>6</issue>), <fpage>943</fpage><pub-id pub-id-type="doi">10.3390/cells11060943</pub-id>.<pub-id pub-id-type="pmid">35326393</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Sueta</surname><given-names>D.</given-names></name>; <name><surname>Tabata</surname><given-names>N.</given-names></name>; <name><surname>Hokimoto</surname><given-names>S.</given-names></name>
<article-title>Clinical roles
of calcium channel
blockers in ischemic heart diseases</article-title>. <source>Hypertension
Research</source>
<year>2017</year>, <volume>40</volume> (<issue>5</issue>), <fpage>423</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1038/hr.2016.183</pub-id>.<pub-id pub-id-type="pmid">28123178</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Godfraind</surname><given-names>T.</given-names></name>
<article-title>Discovery
and development of calcium channel blockers</article-title>. <source>Frontiers in pharmacology</source>
<year>2017</year>, <volume>8</volume>, <fpage>286</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00286</pub-id>.<pub-id pub-id-type="pmid">28611661</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Zyoud</surname><given-names>S. H.</given-names></name>; et al. <article-title>Scientific research related to calcium channel blockers poisoning:
Bibliometric analysis in Scopus, 1968&#x02013;2012</article-title>. <source>Human &#x00026; experimental toxicology</source>
<year>2015</year>, <volume>34</volume> (<issue>11</issue>), <fpage>1162</fpage>&#x02013;<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1177/0960327115571768</pub-id>.<pub-id pub-id-type="pmid">25673180</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Xia</surname><given-names>Y.</given-names></name>; et al. <article-title>GraphBind: protein structural
context embedded rules learned by hierarchical
graph neural networks for recognizing nucleic-acid-binding residues</article-title>. <source>Nucleic acids research</source>
<year>2021</year>, <volume>49</volume> (<issue>9</issue>), <fpage>e51</fpage>&#x02013;<lpage>e51</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab044</pub-id>.<pub-id pub-id-type="pmid">33577689</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Zhang</surname><given-names>J.</given-names></name>; et al. <article-title>SCAMPER: accurate type-specific
prediction of calcium-binding residues
using sequence-derived features</article-title>. <source>IEEE/ACM Transactions
on Computational Biology and Bioinformatics</source>
<year>2023</year>, <volume>20</volume> (<issue>2</issue>), <fpage>1406</fpage>&#x02013;<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.1109/TCBB.2022.3173437</pub-id>.<pub-id pub-id-type="pmid">35536812</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Elnaggar</surname><given-names>A.</given-names></name>; et al. <article-title>Prottrans: Toward understanding
the language of life through self-supervised
learning</article-title>. <source>IEEE transactions on pattern analysis
and machine intelligence</source>
<year>2022</year>, <volume>44</volume> (<issue>10</issue>), <fpage>7112</fpage>&#x02013;<lpage>7127</lpage>. <pub-id pub-id-type="doi">10.1109/TPAMI.2021.3095381</pub-id>.<pub-id pub-id-type="pmid">34232869</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Seo</surname><given-names>S.</given-names></name>; et al. <article-title>DeepFam: deep learning
based alignment-free method for protein family
modeling and prediction</article-title>. <source>Bioinformatics</source>
<year>2018</year>, <volume>34</volume> (<issue>13</issue>), <fpage>i254</fpage>&#x02013;<lpage>i262</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty275</pub-id>.<pub-id pub-id-type="pmid">29949966</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Chawla</surname><given-names>N. V.</given-names></name>; et al. <article-title>SMOTE: synthetic minority over-sampling technique</article-title>. <source>Journal of artificial intelligence research</source>
<year>2002</year>, <volume>16</volume>, <fpage>321</fpage>&#x02013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1613/jair.953</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="book" id="cit29"><person-group person-group-type="allauthors"><name><surname>He</surname><given-names>H.</given-names></name></person-group>; <etal/><article-title>ADASYN: Adaptive synthetic sampling approach
for imbalanced learning</article-title>. <source>2008 IEEE International
Joint Conference on Neural Networks
(IEEE World Congress on Computational Intelligence)</source>; <publisher-name>IEEE</publisher-name>, <year>2008</year>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Xia</surname><given-names>C.-Q.</given-names></name>; <name><surname>Pan</surname><given-names>X.</given-names></name>; <name><surname>Shen</surname><given-names>H.-B.</given-names></name>
<article-title>Protein&#x02013;ligand binding residue prediction enhancement
through hybrid deep heterogeneous learning of sequence and structure
data</article-title>. <source>Bioinformatics</source>
<year>2020</year>, <volume>36</volume> (<issue>10</issue>), <fpage>3018</fpage>&#x02013;<lpage>3027</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa110</pub-id>.<pub-id pub-id-type="pmid">32091580</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Lu</surname><given-names>C.-H.</given-names></name>; et al. <article-title>MIB2: metal ion-binding
site prediction and modeling server</article-title>. <source>Bioinformatics</source>
<year>2022</year>, <volume>38</volume> (<issue>18</issue>), <fpage>4428</fpage>&#x02013;<lpage>4429</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btac534</pub-id>.<pub-id pub-id-type="pmid">35904542</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Mendez</surname><given-names>D.</given-names></name>; et al. <article-title>ChEMBL: towards direct deposition of bioassay data</article-title>. <source>Nucleic acids research</source>
<year>2019</year>, <volume>47</volume> (<issue>D1</issue>), <fpage>D930</fpage>&#x02013;<lpage>D940</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id>.<pub-id pub-id-type="pmid">30398643</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="book" id="cit33"><person-group person-group-type="allauthors"><name><surname>Striessnig</surname><given-names>J.</given-names></name>; <name><surname>Ortner</surname><given-names>N.J.</given-names></name></person-group><article-title>Ca2+ channel blockers</article-title>. In <source>Encyclopedia of
Molecular Pharmacology</source>; <publisher-name>Springer</publisher-name>, <year>2022</year>; p <fpage>375</fpage>&#x02013;<lpage>383</lpage>.</mixed-citation></ref></ref-list></back></article>